TargAnox
Latest round
- Series A
Last raised
- Mar 2009
Total raised
- $5.1M
Investors
- 2
About TargAnox
TargAnox is a domain name sales and leasing company, offering innovative solutions for clients to establish their digital presence.Founded in 2008 and headquartered in Cambridge, US, TargAnox specializes in domain name sales and leasing.1 mn.com, priced at USD 1,999. Customers can opt for either a full payment or a 'Lease to Own' plan, enabling them to pay USD 100 per month.com generates revenue through the direct sale of domain names and the Lease to Own payment structure. The Lease to Own plan creates a recurring revenue stream as customers commit to monthly payments, allowing access to premium domain names without immediate full payment. Secure payment processing enhances customer confidence. The company plans to expand its product offerings and enhance the user experience for domain acquisition. Future projects include developing additional domain names and exploring new markets for domain registration and leasing, particularly targeting areas in Europe and North America by 2025.
Who invested in TargAnox
2 investors across 1 round
See all investors in TargAnox
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 30, 2009
Amount
$5.1M
Investors
Questions about TargAnox
Who invested in TargAnox?
TargAnox has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TargAnox raised?
TargAnox has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TargAnox last raise money?
TargAnox's most recent round on record is a Series A, in Mar 2009.
What does TargAnox do?
TargAnox is a domain name sales and leasing company, offering innovative solutions for clients to establish their digital presence.
Where is TargAnox headquartered?
TargAnox is headquartered in Cambridge, US.
Which VCs invest in companies like TargAnox?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TargAnox's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TargAnox? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.